Literature DB >> 9158823

One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein.

K W Wodzig1, M M Pelsers, G J van der Vusse, W Roos, J F Glatz.   

Abstract

To allow a more rapid determination of heart-type fatty acid-binding protein (FABP) concentration in plasma a direct non-competitive (sandwich-type) ELISA was developed which uses high-affinity monoclonal antibodies to FABP. Total performance time of the one-step immunoassay is 45 min. The standard curve was linear between 0.2-6 micrograms/L, and the within-run and between-run coefficients of variations were below 6 and 11%, respectively. The serum FABP concentration measured in 79 healthy individuals was 1.6 (0.8) [mean (SD), range 0.3-5.0] micrograms/L. The assay can be used for rapid plasma or serum FABP measurement in the early diagnosis of acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9158823     DOI: 10.1177/000456329703400307

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  10 in total

1.  An evidence-based approach to the assessment of heart-type Fatty Acid binding protein in acute coronary syndrome.

Authors:  Karthik Viswanathan; Alistair S Hall; Julian H Barth
Journal:  Clin Biochem Rev       Date:  2012-02

2.  Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke.

Authors:  Michael T Wunderlich; Thorsten Hanhoff; Michael Goertler; Friedrich Spener; Jane F C Glatz; Claus-W Wallesch; Maurice M A L Pelsers
Journal:  J Neurol       Date:  2005-04-18       Impact factor: 4.849

3.  A new principle for rapid immunoassay of proteins based on in situ precipitate-enhanced ellipsometry.

Authors:  M Robers; I J Rensink; C E Hack; L A Aarden; C P Reutelingsperger; J F Glatz; W T Hermens
Journal:  Biophys J       Date:  1999-05       Impact factor: 4.033

4.  Utility of Heart-type Fatty Acid Binding Protein as a New Biochemical Marker for the Early Diagnosis of Acute Coronary Syndrome.

Authors:  Bhakti N Gami; Dharmik S Patel; N Haridas; Kiran P Chauhan; Hitesh Shah; Amit Trivedi
Journal:  J Clin Diagn Res       Date:  2015-01-01

5.  Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.

Authors:  M J de Groot; A M Muijtjens; M L Simoons; W T Hermens; J F Glatz
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

6.  Fatty acid- and cholesterol transporter protein expression along the human intestinal tract.

Authors:  Christiaan J Masson; Jogchum Plat; Ronald P Mensink; Andrzej Namiot; Wojciech Kisielewski; Zbigniew Namiot; Joachim Füllekrug; Robert Ehehalt; Jan F C Glatz; Maurice M A L Pelsers
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

7.  Lifestyle changes and lipid metabolism gene expression and protein content in skeletal muscle of subjects with impaired glucose tolerance.

Authors:  M Mensink; E E Blaak; H Vidal; T W A De Bruin; J F C Glatz; W H M Saris
Journal:  Diabetologia       Date:  2003-07-11       Impact factor: 10.122

8.  Evaluation of the relationship between heart type fatty acid binding protein levels and the risk of cardiac damage in patients with obstructive sleep apnea syndrome.

Authors:  Burcu Oktay; Erdem Akbal; Hikmet Firat; Sadik Ardic; Ramazan Akdemir; Murat Kizilgun
Journal:  Sleep Breath       Date:  2008-01-19       Impact factor: 2.816

9.  Development of a Quantitative Detection Card for Heart-type Fatty Acid-binding Protein based on Background Fluorescence Quenching Immune Chromatography.

Authors:  Wei Zhang; Junlei Chen; Xinxia Li; Yuwen Wang; Jiutong Li
Journal:  J Med Biochem       Date:  2019-03-03       Impact factor: 3.402

Review 10.  Biomarker Development in Cardiology: Reviewing the Past to Inform the Future.

Authors:  Katharine A Kott; Michael Bishop; Christina H J Yang; Toby M Plasto; Daniel C Cheng; Adam I Kaplan; Louise Cullen; David S Celermajer; Peter J Meikle; Stephen T Vernon; Gemma A Figtree
Journal:  Cells       Date:  2022-02-08       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.